Maynard Um
-
-
-
-
-
-
-
Taysha Gene Therapies (TSHA) PT Raised to $13 at Jefferies
-
-
-
-
-
-
-
Taysha Gene Therapies (TSHA) PT Raised to $8 at Citizens on Competitive Advantage
-
-
-
-
-
-
-
Taysha Gene Therapies (TSHA) PT Raised to $12 at Baird
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Taysha Gene Therapies (TSHA)
-
-
-
-
-
-
-
Baird Reiterates Outperform Rating on Taysha Gene Therapies (TSHA); 'Encouraged by FDA Interactions'
-
-
-
-
-
-
-
Taysha Gene Therapies (TSHA) Misses Q3 EPS by 1c
-
-
-
-
-
-
-
BMO Capital Starts Taysha Gene Therapies (TSHA) at Outperform
-
407,055 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

